Filing Details
- Accession Number:
- 0001562180-20-006022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 20:45:02
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-16 20:45:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1636422 | Health Catalyst Inc. | HCAT | Services-Computer Programming, Data Processing, Etc. (7370) | 453337483 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1782932 | G. Timothy Ferris | C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-14 | 2,333 | $11.78 | 7,776 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-14 | 1,994 | $35.39 | 5,782 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-14 | 339 | $35.99 | 5,443 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-14 | 2,333 | $0.00 | 2,333 | $11.78 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
60,167 | 2028-01-24 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 12, 2020, in accordance with Rule 10b5-1.
- Represents the weighted average sale price of the shares sold ranging from $34.94 to $35.82 per share, inclusive.
- Represents the weighted average sale price of the shares sold ranging from $35.94 to $36.09 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and footnote 2.
- 25% of the 62,500 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.